MRI Markers of Feedback Timing During Learning in Individuals with TBI with and Without Clinical Depression
2 other identifiers
interventional
180
1 country
1
Brief Summary
The goal of this proposal is to examine the influence of feedback timing on learning and brain function in individuals with moderate-to-severe traumatic brain injury (TBI), with and without depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2021
CompletedFirst Posted
Study publicly available on registry
August 17, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedOctober 9, 2024
December 1, 2023
4.4 years
July 30, 2021
October 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Learning accuracy
Participants' learning accuracy (in percent) assessed with Eprime software
Collected during the single 1 day study
functional MRI
Participants brain activity
Collected during the single 1 day study
Secondary Outcomes (9)
Verbal Paired Associates test
Collected during the single 1 day study
Logical Memory test
Collected during the single 1 day study
Delis-Kaplan Executive Function System
Collected during the single 1 day study
Test of Premorbid Functioning
Collected during the single 1 day study
Ruff 2 & 7 Selective Attention Test
Collected during the single 1 day study
- +4 more secondary outcomes
Study Arms (4)
Traumatic Brain Injury (TBI)
EXPERIMENTALIndividuals with moderate-to-severe injury severity, defined as post-traumatic amnesia lasting more than 24hrs, loss of consciousness lasting more than 30 min, Glasgow Coma Scale (GCS) score less than 13.
Traumatic Brain Injury (TBI) with MDD
EXPERIMENTALIndividuals with moderate-to-severe injury severity, defined as post-traumatic amnesia lasting more than 24hrs, loss of consciousness lasting more than 30 min, Glasgow Coma Scale (GCS) score less than 13. In addition, individuals will have a diagnosis of major depressive disorder (MDD) as per DSM-5.
Major Depressive Disorder (MDD)
EXPERIMENTALIndividuals meeting criteria for major depressive disorder (MDD) including qualifiers 'in partial remission' or 'in full remission' if they are actively in treatment for the condition and still carry the depression diagnosis.
Healthy Individuals
EXPERIMENTALHealthy individuals without psychiatric and neurological conditions.
Interventions
The goal of this investigation is to examine the influence of feedback timing on learning and brain function.
Eligibility Criteria
You may qualify if:
- I am between the ages of 18 and 65.
- I have been diagnosed with a TBI.
- I am an individual without TBI.
- I am right-handed.
- I have normal vision or corrected to normal vision.
- I can read and speak English fluently.
- I do or do not have a current diagnosis of Depression.
- I am not currently pregnant.
You may not qualify if:
- I have had a neurological disease, other than TBI.
- I have a significant history of alcohol or drug abuse as determined by study staff.
- I have metal in my body (shrapnel, piercing that cannot be taken off, retainer on the upper jaw).
- I have something in my body that restricts me from having an MRI such as: an aneurysm clip; implanted neural stimulator; implanted cardiac pacemaker or auto-defibrillator; cochlear implant (internal hearing aids); ocular foreign body (e.g. metal shavings in my eye), insulin pump or any pre- existing eye conditions (such as blurry vision, seeing double, and abnormal eye movements).
- I experience discomfort in closed spaces (claustrophobia).
- I have been diagnosed with a neurologic illness such as epilepsy, brain tumors, etc. (e.g. schizophrenia and bipolar disorder).
- I have had corticosteroid treatment less than a month ago as determined by study staff review of my medications.
- I have been informed by my doctor that is it unsafe for me to receive regular MRI as part of my medical care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kessler Foundation
West Orange, New Jersey, 07052, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ekaterina Dobryakova, PHD
Kessler Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 30, 2021
First Posted
August 17, 2021
Study Start
September 1, 2021
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
October 9, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share